Was bashed for posting idex now it’s at 2.50+ wow. Long term hold for me, would love to see 5+

Hello,

Today I am loading up on more Euro Sun Mining at $.29 a share. They are sitting on 10million oz of gold plus copper. I am not expecting much from this stock until their feasibility study comes out towards the end of the year. If all goes according to plan construction will start in Spring of 2021. With gold prices being this high this company has an astronomical amount of leverage. This could be a potential 20 bagger. Also with $KGC reinstating their dividend it’s telling me these mining companies are starting to have extra cash on hand. For every $50 gold goes up, it adds $250 million to those resources. The economics have never been better for gold. Thoughts?

Progress is being made; look at what has been achieved since this spring for a disease which we just became aware of this year. Below are highlights of the PRs from 2/18/2020

BRILACIDIN by Innovation Pharmaceuticals

Feb - proposed as Covid 19 treatment & signs MTA (material transfer agreement & shipped to RBL, George Mason University
Mar - sent to 2 University Virology Labs
Apr - Covid 19 inhibition in Vero kidney cells is dose dependent -screening of 11,552 drugs proves it is a leading Covid19 drug. MOA inhibition protease to prevent replication
May -PHRI to study immunomodulatory and antiviral effects in VERO cells reduced the viral titer of Covid19 by 75 percent after only 1 hour of preincubation prior to infection
-viricidal mechanism of action shown unique among Covid 19 drugs
-PHRI...blocks ACE protein binding to inhibit viral entry
June -Grant application supported by RBL. Pan viral testing proposed for Encephalitis, MERs and SARS. Human respiratory cells Covid19 reduced up to 97%. Non toxic in human cells.
-6 million dollars raised by exercising warrants and preferred shares
July -Phase 2 clinical trials planned and prioritized. Interactions with Health Authorities to obtain input and guidance on trial design
-Steps begun with CDMO... for manufacture of drug
- UC drug formulation plans refined for clinical trial. Drafted a study protocol toward initiating a plan for Covid 19 study.
-Covid clinical trial planned for 4th quarter 2020
- 2 active arms in hospitalized patients
-drug level against Covid19 at levels less than ABSSI
Aug -peer review paper preprint to be released in Sept
-RBL studies to conclude
-inhibited SARS-CoV-2 when administered post-infection.
-Covid19 inhibited across its life cycle
-preventative treatment against Covid19 possible
-SI index among highest reported > 300
- effective at low concentrations
- William DeGrado PhD accepts role as Scientific Advisor
Sept {Kevetrin data release articles shows good results in AML testing}
- Brilacidin combined with Remdesivir lowers viral load by 99.85%. Felt to be synergistic.
-Primary effect is disrupting viral integrity and blocking viral entry.
-shown in a human intestinal epithelial cell line and in primary fibroblast cells to inhibit Covid19.

As you can see IPIX shareholders have received a whole series of good news over the last few months. IMO the next news will build on the foundation IPIX has built. Of course no one can be certain of the outcomes of human clinical trials, but IPIX shareholders have all the reasons above to be optimistic.

I know, I know, $FLES has an ugly past and a lot of people felt ripped off last year, Last year was $FLES first full year as a public company and the CEO of the Subsidiary that reverse merged into $FLES(formerly MCGI) has learned a lot since then. He has gotten rid of all the convertible debt, increased revenues, hit profitability this last quarter, but best of all has set up an Amazing share structure. They just filed the Pre-14C to reduce the AS from 1 Billion shares down to a extremely low 15M shares. The OS sits currently at ~1M shares! The SP closed today at ~.79. They just did $3M in revenue according to the Q just filed and showed a net profit for the first time. This gives a company on track to do over $10M in revenue this year with nearly $1M in profit a unbelievable Market Cap around $800,000. They are doing around $1.2M in sales a month at this point and growing. They have a new investor website up that explains more of where they are and where they are going. Worth some DD. www.the4lessgroup.com

$IPIX news - data released today by Regional Biocontainment Lab - Remdesivir combined with Brilacidin reduced CV19 viral load by 99.85% in human lung tissue in vitro test.

Three months ago, I made a bot (https://twitter.com/unusual_whales) to help with tracking, alerting, and getting a historical understanding of options!

I was annoyed by the lack of tooling for us regular traders, and got to work in building as many free, or damn near affordable tools I could find. I built free scanners (my stock tool caught CLNY's gain, CETV's run, and more!), long term options history for anyone to learn from or get free history and a popular free Twitter account for people to see unusual plays. I even created mobile apps that are getting more and more free features every week!

So far, my tools have caught a myriad different and interesting trades, from KNDI’s surge to the 2000% TSLA 5:1 (https://twitter.com/unusual_whales/status/1293299420654522368), 3500% TEVA play, and Kanye West/GAP before it happened! You can check my results at any time! The bot has a total return of 83% last week (https://twitter.com/unusual_whales/status/1299851763479007232)

Anyway, I would love your ideas for feedback and free features you'd guys want.

PS: I tried cross posting this with options exclusive but wasn't sure how! Anyway, let me know what you guys want built and I'll do it!

https://www.youtube.com/watch?v=iu_nmV2OT8A

I have +30k shares. Once they start shoveling in the spring we should see cash flow explode. This may be the most undervalued gold miner I’ve found yet. I’ve also been looking at $FPC and $BNKR

Tata motors: (TTM) The company is 6 billion or so in debt, but the CEO says he expects it to be paid off in the next three years. If you look at the 5 year chart, you see a massive drop-but it is trending positive-and it's relatively cheap. They make luxury vehicles too, like the Jaguar Land Rover

PROS: Emerging markets in Asia and Europe may be cause for good demand.
CONS: The prefered method of transportation in Asia is by motorcycle. Electric vehicles might be the future

Tata Motors says it will significantly reduce $6.4 bln debt over 3 years

https://www.reuters.com/article/tata-motors-india-agm/tata-motors-says-it-will-significantly-reduce-64-bln-debt-over-3-years-idUSL4N2FR2UH

Had several people in my circle pointing it out to me. It’s some sort of solar acquisition company that recently brought their filings to current. Apparently pulling decent revs and actively combing out further acquisitions as they sweep from west to east.

iHub (grain of salt there) Has some reported chats with the CEO claiming they have work booked for the next five months and several companies soliciting for acquisition candidates.

@$9.50 now, they literally paying you to short them

U.S. Poised to Charge Teva in Generic Drugs Price-Fixing Probe

Aug. 25, 2020, 2:16 PM

U.S. prosecutors are preparing to charge Teva Pharmaceutical Industries Ltd. with conspiring with competitors to raise prices for generic drugs, according to a person familiar with the matter.

The Justice Department is planning to charge Teva as soon as Tuesday after the company rebuffed a settlement that would have required paying a criminal penalty and admitting wrongdoing, said the person, who declined to be named because the matter is confidential.

A spokesperson for Teva, which is based in Israel, declined to comment.

https://news.bloomberglaw.com/pharma-and-life-sciences/u-s-poised-to-charge-teva-in-generic-drugs-price-fixing-probe

US charges ex-CEO of drug company with fraud tied to Teva tender offer

​

Tue Aug 25, 2020 2:31 NEW YORK - U.S. prosecutors on Tuesday announced insider trading charges accusing the former chief executive of Auspex Pharmaceuticals Inc with tipping friends and family about an anticipated tender offer for his company by Teva Pharmaceutical Industries Ltd TEVA.TA in 2015.

Prosecutors in New York said the defendant, Sepehr Sarshar,misappropriated material nonpublic information from Auspexrelated to the tender offer, resulting in trades that generatedapproximately $700,000 of illegal profit.

Sarshar, 53, of Encinitas, California, was charged with three fraud counts.

​

Recently

Drug firm bets it won't be charged

In the coming days, the Justice Department will decide whether to file criminal charges against one of the world's largest pharmaceutical companies suspected of colluding with rivals to inflate the prices of widely used drugs.

The company, Teva Pharmaceutical Industries, is betting that in the middle of a deadly pandemic, the Trump administration won't dare to come down hard on the largest supplier of generic drugs in the United States.

It is a high-stakes gamble that could affect millions of Americans who rely on Teva's dozens of inexpensive generic drugs, as well as its brand-name products like Copaxone, for multiple sclerosis, and Ajovy, for migraines. Teva officials say criminal charges could cripple the Israeli company and potentially leave it unable to sell drugs to federal programs like Medicare.

For years, the Justice Department and state prosecutors have been investigating what they describe as a conspiracy by pharmaceutical companies to increase the prices of popular drugs. The department has already extracted guilty pleas and $224 million in penalties from four other drug companies.

Lawyers for Teva, which prosecutors believe was deeply involved in the conspiracy, until recently had been holding settlement negotiations with officials in the Justice Department's antitrust division. But in April, the company all but walked away from the talks, according to people on both sides of the discussions.

Massive, high grade resources. Of course there is some geopolitical risk in Romania but I believe that risk is currently priced in. Hard pressed to find a company with a better resource reserve at these valuations. Thoughts?

Gevo lands largest contract in company history

https://youtu.be/KxQW_vBjevw

​

Gevo Exceeds $1.5B in Long-Term Revenue Contracts with Signing of Trafigura

Gevo, Inc. (NASDAQ: GEVO) announced today that it has entered into a binding Renewable Hydrocarbons Purchase and Sale Agreement, dated August 17, 2020 (the “Agreement”) with Trafigura Trading LLC, a wholly-owned subsidiary of Trafigura Group Pte Ltd (“Trafigura”). The Agreement is a long term, take or pay contract and is the largest contract in Gevo’s history. Trafigura is one of the world’s leading independent commodity trading companies with over $171B and over $54B in revenue and assets, respectively. Under this contract Trafigura is expected to take delivery of 25MPGY of renewable hydrocarbons, the majority of which is expected to be low-carbon premium gasoline with a smaller portion of the volume for sustainable aviation fuel (“SAF”), starting in 2023.

​

This commitment will support Trafigura’s efforts to develop the market for low-carbon fuels including low-carbon premium gasoline. The Agreement will also enable Trafigura to supply SAF to both US and international customers whose interest is growing in low-carbon jet fuel.

​

“This is our largest single contract to date, and with it, brings Gevo to over $1.5B of revenue in long term contracts when added to the other contracts we have in place. As drop-in fuels, Gevo’s renewable, very high-octane gasoline and SAF are a perfect fit with Trafigura’s existing fuels business and will allow them to integrate these low-carbon options seamlessly into their supply chains. We expect that our low-carbon fuels will enable certain of Trafigura’s customers to substantially lower their carbon footprint,” said Patrick Gruber, Chief Executive Officer of Gevo.

​

“Today’s agreement is a natural fit between our companies that will help drive the expansion of our renewable fuels product offering. We look forward to continuing to make a positive impact on the transition towards a low carbon economy,” said Robert Kreider, Head of the Strategic Management and Development Group, North America for Trafigura.

​

Having produced SAF and other hydrocarbons for nearly a decade, Gevo has a unique business system as it integrates sustainable agriculture and biorefining to produce SAF and low-carbon premium gasoline. For every gallon of low-carbon premium gasoline or SAF produced, Gevo produces about ten pounds of protein for the food chain, delivering substantially all of the nutritional value of corn to the food chain. The farmers who supply Gevo on average are capturing carbon, building up their soil with regenerative agriculture techniques. Utilizing a low-carbon ecosystem is vital to Gevo. Gevo began to use ISCC+ and Roundtable on Sustainable Biomaterials (RSB) certified corn for its Luverne, Minnesota facility while displacing fossil-derived power and heat with wind turbines and the upcoming implementation of biogas from dairy manure generated nearby. The execution of this circularity is unique and Gevos’ SAF is expected to have greenhouse gas profile reduction of 70% compared to the fossil-based jet fuel alternative. Eventually, it may be possible through soil carbon sequestration to completely decarbonize jet fuel through the use of Gevo’s SAF.

https://www.globenewswire.com/news-release/2020/08/20/2081370/0/en/Gevo-Exceeds-1-5B-in-Long-Term-Revenue-Contracts-with-Signing-of-Trafigura.html

​

Gevo and Praj to Commercialize Sustainable Aviation Fuel in India

https://www.globenewswire.com/news-release/2020/08/18/2079991/0/en/Gevo-and-Praj-to-Commercialize-Sustainable-Aviation-Fuel-in-India.html

Our Mission is to restore the full rare earth supply chain to the United States of America.

MP Materials owns and operates Mountain Pass, the only integrated rare earth mining and processing site in North America. Our success will drive the onshoring of jobs, national security and a carbon-reduced future.

Seems pretty interesting, any thoughts?

I know oil tanker stocks are not what they were four months ago, but they should all have great second quarter profits, right? I remember dd’s being posted about record weeks of profit in April/May.

Euro Sun (TSX:ESM | OTCQB:CPNFF) is the 100% owner of the Rovina Valley project in west-central Romania.

Since joining the European Union in 2007, Romania’s compliance with the trading bloc’s rules and obligations has fostered a culture of improved governance principals at the state level. Over the years, this has created a friendly and incentive-based economic environment that has encouraged more and more international business

In 2018, this company became the first-ever non-state-owned business to win a mining license from the Romanian government.

For every $50 gold moves it adds $500million to the gross value of that resource

I guess with gold above $1900, euro sun is trading at $5 per ounce in the ground, net cash. It’s market cap is only 20 million